The data show that CXCL12 treatment induces the phosphorylation of PAK4 in a time-dependent manner, which is abrogated upon pre-treatment of PCa cells with a CXCR4 antagonist (AMD3100) (Figure 5A and B). This evidence concerns the gene CXCL12 and posterior cortical atrophy.